Search results
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 24 hours agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19 vaccine for the 2024-2025 fall season...
Novavax seeks FDA approval for updated Covid-19 vaccine
Pharmaceutical Technology via Yahoo Finance· 1 day ago"Novavax seeks FDA approval for updated Covid-19 vaccine" was originally created and published ...
Novavax applies for FDA nod for its updated COVID vaccine
Center for Infectious Disease Research and Policy· 16 hours agoThe company said it will have the vaccine ready to distribute in mid July as prefilled syringes, pending approval and recommendations.
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA Today· 5 days agoCases of the latest COVID-19 variant, also known as KP.3, are on the rise in the United States....
New COVID-19 strain KP.3 circulating in US. What is the situation in Riverside County?
The Desert Sun· 4 days agoA new COVID-19 variant called KP.3 is on the rise in the United States and has been detected in...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 3 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 6 days agoAnd Moderna stock surged more than 9% on Dec. 19, the day it released the news. Moderna also...
Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
BioPharma Dive via Yahoo Finance· 4 days agoThe Japanese pharma paid $100 million to secure option rights to an Ascentage drug. Elsewhere, J.P....
Moderna director Afeyan sells over $30 million in company stock By Investing.com
Investing.com· 7 days agoModerna , Inc. (NASDAQ:MRNA) Director Noubar Afeyan has sold a significant number of company shares,...